Simplification and Test and Treat Strategies Towards Hepatitis C Eliminationplatform" in China(STAT)

Launched by HUASHAN HOSPITAL · Jun 13, 2023

Keywords

ClinConnect Summary

The clinical trial titled "Simplification and Test and Treat Strategies Towards Hepatitis C Elimination in China" aims to better understand how common hepatitis C virus (HCV) infections are among people who are undergoing routine health check-ups or visiting outpatient clinics. Researchers want to establish a simple testing method that can help identify those who might have HCV, with the ultimate goal of eliminating this virus in China.

If you are 18 years or older and have a residual blood sample of at least 1 milliliter, you may be eligible to participate in this study. However, certain individuals—such as pregnant women, those with a history of severe diseases, or anyone already diagnosed with HCV—are not eligible. Participants will be asked to give their consent to take part in the study, and they can expect to provide a blood sample for testing. It's important to know that you can withdraw from the study at any time if you choose to do so. This trial is currently recruiting participants, so if you're interested, it could be a chance to contribute to important research on hepatitis C.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1) 18 years of age and older, regardless of age or gender.
• • 2) The residual blood sample needs to be not less than 1ml.
• • 3) Must have the ability to understand and sign a written informed consent form, which must be obtained prior to initiation of study procedures.
• Exclusion Criteria:
• • 1) Pregnant, lactating female and who is planning pregnancy during study period.
• • 2) History of tumor or other severe, life-threating diseases.
• • 3) Samples not meet collection requirements.
• • 4) repeated enrollment.
• • 5) HCV infection has been diagnosed.
• • 6) Recent HCV RNA testing confirmed that there is no HCV infection.
• Termination criteria:
• • 1) Subject asked to withdraw consent.
• • 2) Subjects may suffer adverse impact from the study at investigator's discretion.